BackGRI Bio Overview

GRI Bio Total Assets

GRI Bio's total assets is $11M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$11.34M
↑ 180.53% YoYΔ $7.30M vs prior year quarter

Peer trimmed avg / median

Loading

GRI Bio Total Assets History

Loading

GRI Bio vs. peers: Total Assets Comparison

Loading

GRI Bio Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

GRI Bio (GRI) FAQ

As of the most recent data (April 2026), GRI shows a total assets of $11M. That compares with $4M in the prior-year period — up 180.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GRI's total assets is now $11M (was $4M) — a 180.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether GRI Bio is outperforming or lagging.

Tracking GRI's total assets over time shows whether GRI Bio is scaling, shrinking, or reshaping that part of the business. The current reading is $11M That compares with $4M in the prior-year period — up 180.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has GRI Bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $11M) with ownership activity and broader fundamentals.

GRI Bio's total assets is $11M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.